Exchange: NASDAQ·Updated 07:58 PM EST

About NRXP

About

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
29

Frequently Asked Questions

Advertisement|Remove ads.